GeneDx Corp (WGS) - Narx-foyda multiplikatori

Sema4 (WGS) korporativ emblemasi va logotipi

GeneDx Holdings Corp. eng yirik ekzom ma'lumotlar bazasi va AI tahlillari tufayli noyob patologiyalarni tashxislash sohasida yetakchilik qilmoqda. Pediatriyada butun genom sekvensirlashning keng joriy etilishi daromadli bo'lish yo'lini tezlashtirmoqda. P/E koeffitsiyenti bozor kutganlarini aks ettiradi, bunda -14.30 ko'rsatkichi joriy baholash darajasini belgilaydi. Robotlashtirilgan liniyalarning modernizatsiyasi va laboratoriyalardan yuqori foydalanish bozor kapitalizatsiyasining yanada o'sishini ta'minlaydi.

genedx.com - WGS Narx-foyda koeffitsiyenti (davr: 28.04.2023 - 16.11.2026)

GeneDx Holdings Corp. kompaniyasining tahliliy kesimlari

- bozor narxi va tahlilchilarning maqsadli narxlari:
Kompaniyaning har tomonlama tahlili:GeneDx
GeneDx yetakchi tovari

GeneDx Holdings Corp. (WGS) yuqori aniqlikdagi pediatrik genetika orqali operatsion daromadlilikka erishmoqda, bunga bo'lgan talab makroiqtisodiy sharoitlardan mustaqil tarzda saqlanib qolmoqda. Foyda ko'rsatkichiga nisbatan narx ko'rsatkichi joriy foydaning bir dollari qiymatini o'lchaydi, bu esa fundamental ishonchlilik va o'sish potentsiali o'rtasidagi muvozanatni baholash imkonini beradi. GeneDx Holdings Corp. (WGS) kompaniyasining joriy bozor P/E ko'rsatkichini tahlil qilish orqali investor biznesning kelajakdagi kengayish sur'atlari uchun to'lanadigan premium miqdorini aniqlaydi.

Muhim raqobatchilar

tempus.com - Kapitalizatsiyaning sof foydaga nisbati|P/E multiplikatori QGEN|Biznesning o‘zini qoplash muddati Isis Pharmaceuticals|P/E multiplikatori RGEN (repligen.com)|Bozor narxining sof foydaga nisbati RNA (Avidity Biosciences, Inc.)|CRSP - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Ultragenyx (RARE)|BEAM: P/E multiplikatori|Sarepta Therapeutics, Inc. (SRPT) - P/E multiplikatori|TWST (twistbioscience.com) - P/E multiplikatori|10x Genomics, Inc. (TXG) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti NTLA (Intellia Therapeutics, Inc.)|STOK - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati biolifesolutions.com BLFS|Biznesning o‘zini qoplash muddati Wave Life Sciences Corp (WVE)|MAZE - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati SION (Sionna Therapeutics Inc)|PRME: P/E multiplikatori|Taysha - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati uniQure NV|Narx-foyda multiplikatori MGTX (MeiraGTx PLC)|Narx-foyda koeffitsiyenti RGNX (regenxbio.com)|Solid Biosciences Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Kapitalizatsiyaning foydaga nisbati|BNTC - Narxning foydaga nisbati|Design Pharma - Bozor narxining sof foydaga nisbati|RCKT (Rocket Pharmaceuticals Inc) - Narx-foyda koeffitsiyenti|4D Molecular Therapeutics (FDMT) - P/E multiplikatori|Narxning foydaga nisbati Lexeo Therapeutics, Inc.|Kapitalizatsiyaning foydaga nisbati Korro Bio, Inc. KRRO|P/E multiplikatori EDIT|Biznesning o‘zini qoplash muddati Silence Therapeutics Corp|Narxning foydaga nisbati proqr.com PRQR|CDXS - Narx-foyda koeffitsiyenti|SGMO - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Nautilus Biotechnology, Inc. (NAUT)|MGX: P/E multiplikatori|Narx-foyda multiplikatori DTIL|GBIO (Generation Bio) - P/E multiplikatori|Narx-foyda multiplikatori BOLD (boundlessbio.com)|Narx-foyda koeffitsiyenti XCUR (exicuretx.com)|Celsion Corporation - Narx-foyda multiplikatori|P/E multiplikatori PHIO (phiopharma.com)|P/E multiplikatori Mustang Bio, Inc. MBIO|RNAZ: Narx-foyda koeffitsiyenti|BNGO (Bionano Genomics) - Narx-foyda multiplikatori|APDN: P/E multiplikatori|bluebird bio (BLUE) - P/E multiplikatori|Narxning foydaga nisbati ImmunoPrecise Antibodies Ltd.|Kapitalizatsiyaning foydaga nisbati Omega OMGA|P/E multiplikatori OMIC|RGLS - Kapitalizatsiyaning foydaga nisbati|Syros Pharmaceuticals, Inc - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Codex DNA (TBIO)|TCON - Narxning foydaga nisbati|UBX: Narxning foydaga nisbati